CHICAGOBUSINESS.COM I FEBRUARY 12, 2024
Will a Shields sale boost Walgreens health care plan? Former CEO Roz Brewer said the specialty pharmacy firm would drive long-term growth. The new boss seems to have other ideas. By Katherine Davis
In 2001, Chicagoans cheered when Boeing picked the Windy City over Dallas and Denver for its new headquarters. | AP IMAGES
Did relocating to Chicago help Boeing or hurt it? The move was based on the professed need to buffer top execs from the distraction of the production plants | By Steven R. Strahler
B
oeing's declaration in the spring of 2001 that it would move its headquarters four months later to Chicago was an unmitigated triumph for a city that had suffered through the loss of prestige companies during the 1990s. But was it good for Boeing? The ensuing decades have seen the once-lauded aerospace firm humbled by a string of disasters, the latest a blowout of a cabin panel in midflight. The Alaska Airlines 737 Max 9 landed safely, and no lives were lost — in contrast to the 346 who died in two 737 See BOEING on Page 23
C-suite people “lost the ability to freely interact with the floor, the engineers and the IAM, the machinists.” — Scott Hamilton, industry analyst
Walgreens Boots Alliance in recent years has spent billions of dollars on various assets it said would prop up a new health care business intended to support the pharmacy chain’s long-term prospects. Shields Health Solutions, a specialty pharmacy firm, was among the companies Deerfieldbased Walgreens added to its portfolio. Walgreens paid more than $2.34 billion over two separate investments into Shields, an asset that was supposed to be key to Walgreens’ transition into a full-fledged health care company. At the time of Walgreens’ second investment into Shields, former CEO Roz Brewer said the deal would “drive sustainable long-term growth.” But new CEO Tim Wentworth seems to have other ideas about the best path forward for Walgreens’ multibillion-dollar health care strategy. Bloomberg News reported Jan. 23 that Walgreens is looking to sell Shields for more than $4 billion, citing people familiar with the matter. A potential deal could help Walgreens refine its growing and ever-important health care segment, as well as shore up Walgreens’ balance sheet — key for a
Tim Wentworth
company that just cut its dividend. And as it's a relatively small part of the business, Walgreens is unlikely to miss it much. “They're now, as a lot of firms are, in a more profit-oriented, macroeconomy,” says Nathan Ray, a partner at Chicago consulting firm West Monroe. “They're just taking a slightly narrower ambition and probably really focusing on the things that they must win, which is (being) the main street corner for retail health consumers." “Walgreens is clearly in possession of assets that define what it should become,” Ray adds. “Shields just doesn't seem to be one of them.” See WALGREENS on Page 20
In health care, tech, architecture, nonprofits and more, these leaders are charting the way. | PAGE 13
VOL. 47, NO. 6 l COPYRIGHT 2024 CRAIN COMMUNICATIONS INC. l ALL RIGHTS RESERVED
GREG HINZ The CTA asked Springfield for money to avoid a fiscal cliff, but the agency needs to help itself, too. PAGE 2
ILLINOIS’ FILM TAX CREDIT A BOON The state has caught the eye of Hollywood studios and producers. PAGE 3
WI OR The lak can lan